Official EU label nameGlossary entry 18690

PALMITAMIDE MEA

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:544-31-0

EC:208-867-9

Ingredient index records:

PALMITAMIDE MEA

Cosmetic functions: ANTISTATIC, SURFACTANT - FOAM BOOSTING, VISCOSITY CONTROLLING

Hexadecanamide, N-(2-hydroxyethyl)-

Open full local profile

2 matched or reported names

PALMITAMIDE MEApalmidrol

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name PALMITAMIDE MEA.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 544-31-0

CAS 544-31-0PubChem CID 4671

Palmitoylethanolamide

Palmitoyl ethanolamide is an N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid. It has a role as an anti-inflammatory drug, an anticonvulsant, an antihypertensive agent and a neuroprotective agent. It is a N-(long-chain-acyl)ethanolamine, an endocannabinoid and a N-(saturated fatty acyl)ethanolamine. It is functionally related to a hexadecanoic acid. — ChEBI

IUPAC name: N-(2-hydroxyethyl)hexadecanamide

Molecular formula: C18H37NO2
Molecular weight: 299.5 g/mol
Exact mass: 299.282429423 Da
XLogP3: 6.2
Topological polar surface area: 49.3 Å²
Hydrogen-bond donors: 2
Hydrogen-bond acceptors: 2
Covalent units: 1
Defined stereocentres: 0

Also known as

PalmidrolPalmitoyl ethanolamidePalmitic acid monoethanolamideHydroxyethylpalmitamideLoramine P 256palmitylethanolamidePalmidrolumLevagen

16 more reported names

Palmdrol prodesMonoethanolamine palmitic acid amidepalmitic monoethanolamidePalmitinsaeure-beta-hydroxyethylamidAnandamide (16:0)hexadecanoyl ethanolamideN(2-hydroxyethyl)palmitide6R8T1UDM3VN(2-hydroxyethyl) palmitideNSC-23320N-(2-hydroxyethyl)-palmitideFSD-201n-palmitoyl ethanolamideAM 3112CHEBI:71464SCI-110 component palmitoylethanolamide

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:71464
ChEMBL:CHEMBL417675
EPA DTXSID:DTXSID4042254
PubMed:23108549
PubMed:23046519
PubMed:23028630
PubMed:22972997
PubMed:22916199
PubMed:22912814
PubMed:22912680
PubMed:22884901
PubMed:22860206
PubMed:22860123
PubMed:22845893
PubMed:22825852

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision